Tumor immunology, toward a success story?

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Sautès Fridman, Catherine ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Immune checkpoints; Immune escape; Immunotherapy; Microbiota; Tumor microenvironment

Indexed keywords

CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMMENSAL; DENDRITIC CELL; EFFECTOR CELL; GENETIC DATABASE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; LYMPH VESSEL; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MEMORY CELL; NONHUMAN; NOTE; SUPPRESSOR CELL; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT;

EID: 84926657567     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00065     Document Type: Note

References (5)

1. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 410:1107-11. doi: 10.1038/35074122
2. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 313:1960-4. doi:10.1126/science.1129139
3. Dieu-Nosjean MC, Goc J, Giraldo NA, Sautés-Fridman C, Fridman WH. Tertiary lymphoïd structures in cancer and beyond. Trends Immunol (2014) 35:571-80. doi:10.1016/j.it.2014.09.006
4. Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer (2012) 12:298-306. doi:10.1038/nrc3245
5. Wolchock JD, Chan TM. Antitumor immunity gets a boost. Nature (2014) 515:496-7. doi:10.1038/515496a